Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection.
IntroductionCoronavirus disease 2019 (COVID‐19) is characterized by a high contagiousness requiring isolation measures. At this time, diagnosis is based on the positivity of specific RT‐PCR and/or chest computed tomography scan, which are time‐consuming and may delay diagnosis. Complete blood count (CBC) can potentially contribute to the diagnosis of COVID‐19. We studied whether the analysis of cellular population data (CPD), provided as part of CBC‐Diff analysis by the DxH 800 analyzers (Beckman Coulter), can help to identify SARS‐CoV‐2 infection.MethodsCellular population data of the different leukocyte subpopulations were analyzed in 137 controls, 322 patients with proven COVID‐19 (COVID+), and 285 patients for whom investigations were negative for SARS‐CoV‐2 infection (COVID−). When CPD of COVID+ were different from controls and COVID− patients, we used receiver operating characteristic analysis to test the discriminating capacity of the individual parameters. Using a random forest classifier, we developed the algorithm based on the combination of 4 monocyte CPD to discriminate COVID+ from COVID− patients. This algorithm was tested prospectively in a series of 222 patients referred to the emergency unit.ResultsAmong the 222 patients, 86 were diagnosed as COVID‐19 and 60.5% were correctly identified using the discriminating protocol. Among the 136 COVID− patients, 10.3% were misclassified (specificity 89.7%, sensitivity 60.5%). False negatives were observed mainly in patients with a low inflammatory state whereas false positives were mainly seen in patients with sepsis.ConclusionConsideration of CPD could constitute a first step and potentially aid in the early diagnosis of COVID‐19.
Read more